A new biomarker function for a long-known hormone
Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients
Adiponectin is a hormone with well-known relevance to cardiac and renal function. As Fabry disease (FD), a rare metabolic disorder, often manifests with cardiac and/or renal symptoms, researchers at CENTOGENE examined a potential link to adiponectin. Their finding of plasma adiponectin levels to correlate with heart and kidney damage in FD patients were published in the journal Blood Cells, Molecules, and Diseases.
Authors
- Marina Hovakimyan , PhD
- VAN Talabattula
- Dr. rer. nat. Claudia Cozma , MD
- Christian Beetz
- Prof. Arndt Rolfs , MD
- Deborah Elstein